< Back to previous page
Researcher
Wim Nerinckx
- Disciplines:Analytical biochemistry, Cell death and senescence, Analysis of next-generation sequence data, General diagnostics
Affiliations
- Saelens Lab (Research group)
Member
From1 Nov 2020 → 31 Oct 2022 - Callewaert Lab (Research group)
Member
From1 Jan 2017 → Today
Publications
1 - 5 of 5
- An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models(2021)
Authors: Bert Schepens, Loes van Schie, Wim Nerinckx, Kenny Roose, Wander Van Breedam, Simon Devos, Wannes Weyts, Sieglinde De Cae, Chiara Lonigro, Hannah Eeckhaut, et al.
Pages: eabi7826 - The Inhibitor Endosidin 4 Targets SEC7 Domain-Type ARF GTPase Exchange Factors and Interferes with Subcellular Trafficking in Eukaryotes(2018)
Authors: Qing Lu, Wim Nerinckx, Riet De Rycke, Eugenia Russinova
Pages: 2553-2572 - Tozasertib Analogues as Inhibitors of Necroptotic Cell Death(2018)
Authors: Sofie Martens, Wim Nerinckx, Nozomi Takahashi, Vera Goossens, Peter Vandenabeele
Pages: 1895-1920 - Nonselective Chemical Inhibition of Sec7 Domain-Containing ARF GTPase Exchange Factors(2018)
Authors: Qing Lu, Riet De Rycke, Marine Bretou, Steven De Munck, Isha Sharma, Le Son Long Nguyen, Andrzej Drozdzecki, Wim Nerinckx, Dominique Audenaert, Savvas Savvides, et al.
Pages: 2573-2593 - When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157(2017)
Authors: Diego Rojas Rivera, Tinneke Delvaeye, Ria Roelandt, Wim Nerinckx, Peter Vandenabeele, Mathieu Bertrand
Pages: 1100-1110
Patents
1 - 10 of 10
- CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR BINDERS (Inventor)
- SARBECOVIRUS BINDERS (Inventor)
- CORONA VIRUS BINDERS (Inventor)
- CORONA VIRUS BINDERS (Inventor)
- PAN-SPECIFIC CORONA VIRUS BINDERS (Inventor)
- CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR BINDERS (Inventor)
- SARBECOVIRUS BINDERS (Inventor)
- CORONA VIRUS BINDERS (Inventor)
- GLYCOSYLATION OF IMMUNOGLOBULIN DOMAINS (Inventor)
- GLYCOSYLATION OF IMMUNOGLOBULIN DOMAINS (Inventor)